Conditions: Schizophrenia Bipolar Disorder
Keywords: Schizophrenia bipolar disorder Lurasidone Latuda
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 162
Healthy volunteers: no

Brief summary:
This is an open-label continuation study designed to monitor the safety, tolerability and effectiveness of lurasidone in subjects who have completed participation in a lurasidone extension study (NCT00868959 and NCT01566162) and who may benefit from continued treatment with lurasidone.

Detailed description:

Arms:
arm 1: Lurasidone flexibly dosed

Interventions: intervention 1: Lurasidone
Intervention descriptions: intervention 1: Lurasidone flexibly dosed; doses of 20, 40, 60 or 80 mg/day will be taken orally with food

Protocol document: